ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652168; 2) Community: the network communities that were significantly associated with the response to NSC 652168; 3) Molecule: the relationships between components within communities and NSC 652168; 4) MDR: the compounds that were significantly associated with the NSC 652168.

NSC Compound Enrichment Correlation
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0422011701988039 0.16021641
NSC 756173 GSK326090A 0.0422011701988039 0.20319223
NSC 87500 Solacongestidine 0.0422011701988039 0.14118842
NSC 113943 6-Bromosangivamycin 0.0438391811600409 0.098533279
NSC 129185 Melbex 0.0438391811600409 -0.00050967634
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0438391811600409 0.20040008
NSC 176323 Camptothecin Derivative 0.0438391811600409 -0.015633434
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0438391811600409 0.077236646
NSC 22070 Chrysanthin 0.0438391811600409 0.31894559
NSC 237671 Actinomycin X4357g-methoxime 0.0438391811600409 0.25362854
Total:105  Current:85    [First] [Prev] [Next] [Last]